- Conditions
- Abnormalities, Multiple, Adenoma, Adenoma, Islet Cell, +31 more
- Locations
-
- Cedars-Sinai Medical Center ( Site 0110) Los Angeles, California, United States
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) Chicago, Illinois, United States
- Northwestern Medicine Cancer Center - Warrenville ( Site 0134) Warrenville, Illinois, United States
- University of Iowa ( Site 0104) Iowa City, Iowa, United States
Clinical trial condition
Pheochromocytoma/Paraganglioma
Explore clinical trials studying Pheochromocytoma/Paraganglioma. Study availability and eligibility vary by location and protocol.
6 public trials
5 recruiting studies
Pheochromocytoma/Paraganglioma trial results
NCT07680205
- Conditions
- Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +13 more
- Locations
-
- Cambridge University Hospitals NHS Foundation Trust Cambridge, Cambridgeshire, United Kingdom
NCT03050268
- Conditions
- AML, Abnormalities, Multiple, Acute Leukemia, +206 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Recruiting
Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial
NCT07167329
- Conditions
- Abnormalities, Multiple, Adenocarcinoma, Angiomatosis, +44 more
- Locations
-
- AC Camargo Cancer Center São Paulo, Brazil
NCT06683846
- Conditions
- Adenocarcinoma, Adrenal Cortical Cancer, Angiomyolipoma, +56 more
- Locations
-
- Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
Not Yet Recruiting
A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies
NCT07621146
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +15 more
- Locations
-
- BC Cancer Vancouver Vancouver, British Columbia, Canada